Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 6/20 | 0.59 |
| ▸ | CYP2E1 | P05181 | 1/20 | 0.52 |
| ▸ | MAOB | P27338 | 11/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.51 |
| ▸ | CALML3 | P27482 | 1/20 | 0.51 |
| ▸ | SDHA | P31040 | 1/20 | 0.51 |
| ▸ | F10 | P00742 | 7/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27314349 | 1.00 | MAOA (0.59) | MAOACYP2E1MAOBLMNAPTGS1 | |
| SCHEMBL27314353 | 1.00 | MAOA (0.59) | MAOACYP2E1MAOBLMNAPTGS1 | |
| SCHEMBL30817026 | 1.00 | MAOA (0.59) | MAOACYP2E1MAOBLMNAPTGS1 | |
| SCHEMBL30817033 | 1.00 | MAOA (0.59) | MAOACYP2E1MAOBLMNAPTGS1 | |
| SCHEMBL30817019 | 1.00 | MAOA (0.59) | MAOACYP2E1MAOBLMNAPTGS1 | |
| SCHEMBL30817027 | 0.90 | MAOA (0.56) | MAOACYP2E1MAOBLMNAPTGS1 | |
| SCHEMBL27314190 | 0.90 | MAOA (0.56) | MAOACYP2E1MAOBLMNAPTGS1 | |
| SCHEMBL27314185 | 0.90 | MAOA (0.56) | MAOACYP2E1MAOBLMNAPTGS1 | |
| SCHEMBL5833650 | 0.89 | MAOB (0.65) | MAOACYP2E1MAOBLMNAPTGS1 | |
| SCHEMBL5833644 | 0.89 | MAOB (0.65) | MAOACYP2E1MAOBLMNAPTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024069378-A1 | NOVEL COMPOUNDS FOR THE TREATMENT OF MAMMALIAN INFECTIONS | ZYDUS LIFESCIENCES LIMITED (IN) | 2024-04-04 | — | — | WO | claimed |
| WO-2024069378-A1 | NOVEL COMPOUNDS FOR THE TREATMENT OF MAMMALIAN INFECTIONS | ZYDUS LIFESCIENCES LIMITED (IN) | 2024-04-04 | — | — | WO | disclosed |